Stock OPRX OPTIMIZERX CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News OptimizeRx Corporation

Equities

OPRX

US68401U2042

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-25 EDT 		5-day change 1st Jan Change
10.21 USD -1.64% Intraday chart for OptimizeRx Corporation -5.64% -28.65%
06-05 Transcript : OptimizeRx Corporation - Shareholder/Analyst Call
05-14 Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations
AQ
Transcript : OptimizeRx Corporation - Shareholder/Analyst Call
Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024
OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q1 Revenue $19.7M, vs. Street Est of $18.1M
MT
OptimizeRx Reports First Quarter 2024 Financial Results
AQ
OptimizeRx to Participate in Upcoming Investor Conferences 
AQ
OptimizeRx Corporation Provides Earnings Guidance for the First Quarter of 2024
CI
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
AQ
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
AQ
Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M
MT
Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 EPS $0.26
MT
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
AQ
OptimizeRx Corporation Reiterates Financial Guidance for the Full Year 2024
CI
OptimizeRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
OptimizeRx : ESG Report
PU
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
AQ
OptimizeRx : Corporate Presentation
PU
JMP Securities Initiates Coverage on OptimizeRx With Market Perform Rating, $15 Price Target
MT
OptimizeRx Expected to Meet 2024 Guidance, RBC Says; Shares Drop
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OPRX Stock
  4. News OptimizeRx Corporation